Long-Term Survival of Patients with Advanced/Metastatic Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Who Received the T-Cell Receptor T-Cell Therapy, Afamitresgene Autoleucel, in the Phase 2 Spearhead-1 Trial
Sandra P. D’Angelo, Mihaela Druta, Brian A. Van Tine, Scott M. Schuetze, Jean Yves Blay, Claudia Maria Valverde Morales, Édouard Forcade, Kristen N. Ganjoo, Axel Le Cesne, Sandra J. Strauss, Dejka M. Araujo, Edwin Choy, Christopher D. Dupont, Dennis Williams, Jane P. F. Bai, Lilliam Fernandes, Erin Van Winkle, Amber K. O’Connor, Elliot Norry (2025). Long-Term Survival of Patients with Advanced/Metastatic Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Who Received the T-Cell Receptor T-Cell Therapy, Afamitresgene Autoleucel, in the Phase 2 Spearhead-1 Trial. , 31(2), DOI: https://doi.org/10.1016/j.jtct.2025.01.380.
